Literature DB >> 3159623

The nucleotide sequence of the early region of the Tupaia adenovirus DNA corresponding to the oncogenic region E1b of human adenovirus 7.

R M Flügel, H Bannert, S Suhai, G Darai.   

Abstract

The nucleotide sequence of the early region E1b of the tree shrew (Tupaia) adenovirus (TAV) DNA has been determined. The sequenced region includes the genes for polypeptides of Mr 15 000, 44 000 and 13 400, which are analogous to the small and large E1b proteins and protein IX, respectively, of the three human adenovirus serotypes 5, 7, and 12. The hexanucleotide consensus signal AATAAA occurs only at the 3' terminus of the gene for protein IX suggesting that the E1 region of TAV encompasses one transcription unit. The amino acid sequences of the TAV polypeptides have a higher degree of homology to those of Ad7 and Ad5 than to those of Ad12.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159623     DOI: 10.1016/0378-1119(85)90296-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Nucleotide sequence analysis of a cloned DNA fragment from human cells reveals homology to retrotransposons.

Authors:  R M Flügel; B Maurer; H Bannert; A Rethwilm; P Schnitzler; G Darai
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function.

Authors:  A O Ball; M E Williams; K R Spindler
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Molecular anatomy of Tupaia (tree shrew) adenovirus genome; evolution of viral genes and viral phylogeny.

Authors:  Udo Bahr; Eva Schöndorf; Michaela Handermann; Gholamreza Darai
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

4.  Characterization of the complete genome of the Tupaia (tree shrew) adenovirus.

Authors:  Eva Schöndorf; Udo Bahr; Michaela Handermann; Gholamreza Darai
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.